American Well Past Earnings Performance
Past criteria checks 0/6
American Well's earnings have been declining at an average annual rate of -43.3%, while the Healthcare Services industry saw earnings growing at 2.8% annually. Revenues have been growing at an average rate of 12.4% per year.
Key information
-43.3%
Earnings growth rate
6.5%
EPS growth rate
Healthcare Services Industry Growth | 1.7% |
Revenue growth rate | 12.4% |
Return on equity | -141.4% |
Net Margin | -260.6% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Not Many Are Piling Into American Well Corporation (NYSE:AMWL) Stock Yet As It Plummets 27%
Apr 02Is American Well (NYSE:AMWL) In A Good Position To Deliver On Growth Plans?
Mar 19American Well Corporation's (NYSE:AMWL) Share Price Not Quite Adding Up
Dec 25Will American Well (NYSE:AMWL) Spend Its Cash Wisely?
Nov 28Amwell Looks To 2024 For Stabilization But Operating Losses Remain High
Nov 08We're Keeping An Eye On American Well's (NYSE:AMWL) Cash Burn Rate
Aug 30American Well Reduces Revenue Guidance On Converge Replatforming Progress (Downgrade)
Aug 11American Well Corporation (NYSE:AMWL) Shares Could Be 24% Above Their Intrinsic Value Estimate
Aug 01American Well Corp.: Reiterate Hold As I Await Converge To Be Fully Implemented
Jun 06What American Well Corporation's (NYSE:AMWL) P/S Is Not Telling You
May 18We Think American Well (NYSE:AMWL) Needs To Drive Business Growth Carefully
Apr 17American Well GAAP EPS of -$0.99 misses by $0.73, revenue of $79.2M beats by $1.15M
Feb 22American Well Grows Converge Activity But Operating Losses Remain High
Jan 31American Well: Hold Off Purchase Until Path To Profitability Is Clear
Jan 18American Well GAAP EPS of -$0.25 beats by $0.01, revenue of $64.52M beats by $0.39M
Aug 04Amwell: Still Not Very Well
Jul 25Amwell: Too Long Of A Path
Apr 09Revenue & Expenses BreakdownBeta
How American Well makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 259 | -675 | 209 | 106 |
30 Sep 23 | 268 | -688 | 220 | 107 |
30 Jun 23 | 275 | -621 | 226 | 116 |
31 Mar 23 | 277 | -598 | 220 | 127 |
31 Dec 22 | 277 | -270 | 204 | 138 |
30 Sep 22 | 271 | -257 | 207 | 145 |
30 Jun 22 | 264 | -238 | 193 | 136 |
31 Mar 22 | 259 | -207 | 181 | 121 |
31 Dec 21 | 253 | -176 | 151 | 107 |
30 Sep 21 | 240 | -179 | 158 | 99 |
30 Jun 21 | 241 | -190 | 173 | 97 |
31 Mar 21 | 249 | -239 | 227 | 93 |
31 Dec 20 | 245 | -224 | 221 | 84 |
30 Sep 20 | 230 | -197 | 205 | 73 |
30 Jun 20 | 202 | -157 | 174 | 61 |
31 Mar 20 | 169 | -90 | 107 | 56 |
31 Dec 19 | 149 | -87 | 100 | 54 |
31 Dec 18 | 114 | -53 | 68 | 36 |
Quality Earnings: AMWL is currently unprofitable.
Growing Profit Margin: AMWL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AMWL is unprofitable, and losses have increased over the past 5 years at a rate of 43.3% per year.
Accelerating Growth: Unable to compare AMWL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AMWL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (15.4%).
Return on Equity
High ROE: AMWL has a negative Return on Equity (-141.44%), as it is currently unprofitable.